Table 4 Cardiovascular complications and comorbidities among the severity of COVID-19 patients
Complications | Total (n = 730) | Mild (n = 309) | Moderate (n = 139) | Severe (n = 282) | p-value |
|---|---|---|---|---|---|
All-cause mortality (n, %) | 166 (22.7%) | 19 (6.1%) | 4 (2.9%) | 143 (50.7%) | < 0.001 |
ACS (n, %) | 67 (9.2%) | 32 (10.4%) | 11 (7.9%) | 24 (8.5%) | 0.959 |
AWMI | 14 (20.9%) | 6 (18.8%) | 4 (36.4%) | 4 (16.7%) | |
IWMI | 10 (14.9%) | 6 (18.8%) | 1 (9.1%) | 3 (12.5%) | |
IPWMI | 2 (2.9%) | 2 (6.3%) | 0 (0%) | 0 (0%) | |
NSTEMI | 41 (61.2%) | 18 (56.3%) | 6 (54.6%) | 17 (70.8%) | |
Myocarditis (n, %) | 60 (8.2%) | 25 (8.1%) | 12 (8.6%) | 23 (8.2%) | 0.968 |
AF (n, %) | 18 (2.5%) | 11 (3.6%) | 1 (0.7%) | 6 (2.1%) | 0.03 |
Cardiogenic shock (n, %) | 3 (0.4%) | 1 (0.3%) | 1 (0.7%) | 1 (0.4%) | 0.603 |
Acute kidney injury (n, %) | 70 (9.6%) | 16 (5.2%) | 8 (5.8%) | 46 (16.3%) | < 0.001 |
PE (n, %) | 25 (3.4%) | 10 (3.2%) | 4 (2.9%) | 11 (3.9%) | 0.896 |
Intracardiac thrombus (n, %) | 4 (0.5%) | 1 (0.3%) | 1 (0.7%) | 2 (0.7%) | 0.681 |
DM (n, %) | 407 (55.8%) | 139 (45%) | 84 (60.4%) | 184 (65.2%) | < 0.001 |
HTN (n, %) | 349 (47.8%) | 129 (41.7%) | 71 (51.1%) | 149 (52.8%) | 0.018 |
CKD (n, %) | 92 (12.6%) | 34 (11%) | 12 (8.6%) | 46 (16.3%) | 0.05 |
CVA (n, %) | 35 (4.8%) | 16 (5.2%) | 5 (3.6%) | 14 (5%) | 0.831 |